A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine

被引：0

作者：

Judy Illes

Douglas Sipp

Erika Kleiderman

Shelly Benjaminy

Rosario Isasi

Geoff Lomax

Zubin Master

Jennifer McCormick

Ubaka Ogbogu

Vardit Ravitsky

Julie M. Robillard

Fabio Rossi

Brenda Wilson

Amy Zarzeczny

机构：

[1] University of British Columbia,National Core for Neuroethics, Division of Neurology, Department of Medicine

[2] RIKEN Center for Developmental Biology,Centre of Genomics and Policy

[3] Keio University School of Medicine,National Core for Neuroethics and Department of Experimental Medicine

[4] Keio Global Research Institute,John T. Macdonald Foundation Department of Human Genetics

[5] McGill University,Alden March Bioethics Institute

[6] University of British Columbia,Department of Humanities

[7] University of Miami,Faculties of Law and Pharmacy & Pharmaceutical Sciences

[8] California Institute of Regenerative Medicine,Bioethics Program, School of Public Health

[9] Albany Medical College,Department of Medical Genetics

[10] Pennsylvania State College of Medicine,School of Epidemiology, Public Health and Preventive Medicine

[11] University of Alberta,Johnson Shoyama Graduate School of Public Policy

[12] University of Montreal,undefined

[13] University of British Columbia,undefined

[14] University of Ottawa,undefined

[15] University of Regina,undefined

来源：

npj Regenerative Medicine | / 2卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building.

引用

共 46 条

[1]

Isasi R(2016)Editing policy to fit the genome? Science 351 337-339

[2]

Kleiderman E(2011)From banking to international governance: fostering innovation in stem cell research Stem Cells Inter. 2011 498132-580

[3]

Knoppers BM(2012)Stem cell network: world’s first stem cell network remains true to mission Stem Cells Transl. Med. 8 579-171

[4]

Isasi R(2016)Revisit the 14-day rule Nat. Regen. Med. 533 169-6

[5]

Knoppers BM(2015)Research ethics and stem cells: is it time to re-think current approaches to oversight? EMBO Rep. 16.1 2-212

[6]

Lyall D(2013)Incorporating exclusion clauses into informed consent for biobanking Camb. Q. Healthc. Ethics 22 203-867

[7]

Hyun I(2017)Informed consent N. Engl. J. Med. 376 856-129

[8]

Wilkerson A(2015)The DISCUSS project: revised points to consider for the derivation of induced pluripotent stem cell lines from previously collected research specimens Stem Cells Transl. Med. 4 123-888

[9]

Johnson J(2016)Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era BMC Med. Ethics 17 39-356

[10]

Caulfield. T(2012)Biobanks, consent, and claims of consensus Nat. Methods 9 885-657

← 1 2 3 4 5 →